Small Business Technology Transfer (STTR) Program
See active R41/R42 funding opportunities
A set-aside program designed to support innovative research that has the potential for commercialization of the subject research conducted cooperatively by a small business concern and a research institution. Innovation and the potential for commercialization are two important aspects of the review criteria considered in the scientific and technical merit evaluation process. At least 40% of the research project is to be conducted by the small business concern, and at least 30% of the work is to be conducted by the single, partnering research institution.
- Phase I (R41): Normally provided for one year/$150,000, which includes direct cost, facilities and administrative cost (F&A/indirect), and fee. The F&A/indirect cost maximum is 40%, if no current negotiated rate.
- Phase II (R42): Normally provided for two years/$1,000,000, which includes direct cost, F&A/indirect cost, and fee. The F&A/indirect cost maximum is 40% or current negotiated rate. The applicant may negotiate with NIH.
A reasonable fee, not to exceed 7% of total costs (direct and indirect) for each Phase (I and II) of the project, can be requested solely to small business concerns receiving awards under the STTR program.
With appropriate justification from the applicant, Congress will allow awards to exceed the normal guidelines by up to 50% ($225,000 for Phase I and $1,500,000 for Phase II). We encourage applicants to contact the program officials prior to submitting any application in excess of the guidelines.
Contact: Xibin Wang email@example.com
Applications Due: April 5, September 5, January 5
Additional Information: Office of Extramural Research: Small Business Innovation Research (SBIR) and Small Business Technology (STTR) Programs.